Saltar al contenido
Merck

Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.

Bioorganic & medicinal chemistry (2009-03-28)
Clarina I Manley-King, Gisella Terre'Blanche, Neal Castagnoli, Jacobus J Bergh, Jacobus P Petzer
RESUMEN

Based on a recent report that 1-methyl-3-phenylpyrrolyl analogues are moderately potent reversible inhibitors of the enzyme monoamine oxidase B (MAO-B), a series of structurally related N-methyl-2-phenylmaleimidyl analogues has been prepared and evaluated as inhibitors of MAO-B. In general, the maleimides were more potent competitive inhibitors than the corresponding pyrrolyl analogues. N-Methyl-2-phenylmaleimide was found to be the most potent inhibitor with an enzyme-inhibitor dissociation constant (K(i) value) of 3.49 microM, approximately 30-fold more potent than 1-methyl-3-phenylpyrrole (K(i)=118 microM). This difference in activities may be dependent upon the ability of the maleimidyl heterocyclic system to act as a hydrogen bond acceptor. This is in correspondence with literature reports which suggest that hydrogen bond formation is involved in stabilizing inhibitor-MAO-B complexes. Also reported here is a brief kinetic study of the hydrolysis of the N-methyl-2-phenylmaleimidyl analogues in aqueous solution. The findings of the inhibition studies are discussed with reference to the rate and extent of hydrolysis.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
N-Ethylmaleimide, purum p.a., ≥99.0% (HPLC)
Sigma-Aldrich
N-Ethylmaleimide, crystalline, ≥98% (HPLC)
Sigma-Aldrich
N-Ethylmaleimide, BioXtra, ≥98% (HPLC)